By Stewart Eisenhart, Emergo Group
Brazil’s medical device market regulator ANVISA now requires clinical data for all novel medical device registrations as well as for some high-risk devices for which clinical investigations are deemed necessary.
Get the full story here at the Emergo Group’s blog.
The opinions expressed in this blog post are the author’s only and do not necessarily reflect those of MassDevice.com or its employees.
The post Brazilian ANVISA issues clinical data requirements for novel medical devices appeared first on MassDevice.
